Share Price and Basic Stock Data
Last Updated: November 3, 2025, 9:24 pm
| PEG Ratio | 3.35 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Mastek Ltd, operating in the IT Consulting and Software sector, reported a market capitalization of ₹6,717 Cr and a current share price of ₹2,168. The company has demonstrated impressive revenue growth, with sales rising from ₹2,184 Cr in FY 2022 to ₹2,563 Cr in FY 2023, and further projected to reach ₹3,055 Cr in FY 2024 and ₹3,455 Cr in FY 2025. The trailing twelve months (TTM) revenue stood at ₹3,557 Cr, indicating a strong upward trajectory. Quarterly sales figures reflect this growth, with the latest reported quarter (Sep 2023) recording sales of ₹766 Cr, up from ₹709 Cr in Mar 2023. This consistent increase underscores Mastek’s ability to capture market demand effectively. The company’s operating profit margin (OPM) has fluctuated but remained relatively stable around 15-18%, suggesting that it maintains adequate control over expenses while scaling operations. Mastek’s revenue from operations per share as of Mar 2025 was ₹1,116.75, showcasing its efficiency in generating sales relative to its share base.
Profitability and Efficiency Metrics
Mastek’s profitability metrics indicate a robust financial performance, with a net profit of ₹396 Cr for the TTM, reflecting a net profit margin of approximately 10.88% for FY 2025. The operating profit for the same period was ₹546 Cr, with an OPM of 16%, which is commendable for the IT consulting sector. The return on equity (ROE) stood at 16.1%, while the return on capital employed (ROCE) was recorded at 17.3%, both of which are strong indicators of effective capital utilization compared to industry averages. The interest coverage ratio (ICR) of 13.52x illustrates that Mastek comfortably meets its interest obligations, providing a cushion against financial distress. Additionally, the cash conversion cycle (CCC) was reported at 78 days, indicating a reasonable time frame to convert investments into cash flow. However, the slight decline in OPM from previous years, coupled with rising expenses, suggests that Mastek must remain vigilant in managing costs as it scales.
Balance Sheet Strength and Financial Ratios
Mastek’s balance sheet reflects solid financial health, characterized by total assets of ₹3,848 Cr and total liabilities of ₹3,848 Cr as of Mar 2025. The company’s reserves have grown significantly, reaching ₹2,447 Cr, which enhances its equity base and provides a buffer for future investments and growth opportunities. The debt levels are manageable, with borrowings recorded at ₹583 Cr, leading to a total debt-to-equity ratio of 0.22, indicating a conservative leverage stance compared to industry norms. The current ratio of 1.95 suggests that Mastek is well-positioned to cover its short-term obligations, while the quick ratio also mirrors this strength. Furthermore, the price-to-book value (P/BV) ratio stood at 2.74x, reflecting a premium valuation that may signal investor confidence in future growth potential. However, the declining trend in some profitability margins, alongside increasing expenses, requires careful monitoring to ensure sustained financial robustness.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Mastek Ltd reveals a diversified ownership structure, with promoters holding 35.79% of the company, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold 11.24% and 11.52%, respectively. The public holds a significant 41.45%, with the total number of shareholders reported at 1,00,780 as of Mar 2025. This distribution indicates a healthy level of retail investor participation, which is often a positive sign for market stability. Over the past year, promoter holdings have decreased slightly from 36.75% in Mar 2023 to 35.79%, which could reflect a strategic dilution or a response to market dynamics. Conversely, FIIs have shown a modest increase in their stake, rising from 10.00% in Mar 2025 to 11.05% in Jun 2025, indicating growing confidence among institutional investors. The consistent interest from DIIs further supports the notion that Mastek is viewed favorably in the market, although fluctuations in promoter stakes might raise questions regarding their commitment.
Outlook, Risks, and Final Insight
Mastek Ltd is poised for continued growth, bolstered by its strong revenue trajectory and efficient operations. However, it faces several risks that could impact its performance. The increasing expenses, reflected in the rising costs reported in the quarterly financials, may compress margins if not managed effectively. Additionally, the fluctuating OPM suggests potential challenges in maintaining profitability amidst rising operational costs. Market competition in the IT consulting space is fierce, and Mastek must innovate and adapt to sustain its market position. On the upside, the company’s solid balance sheet and strong institutional support provide a foundation for strategic investments and growth initiatives. Should Mastek effectively manage its cost structure and capitalize on market opportunities, it could enhance shareholder value significantly. Conversely, failure to navigate these challenges could hinder its growth prospects. Overall, Mastek’s robust fundamentals and market position offer a compelling case for investors, albeit with caution regarding the potential risks ahead.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Mastek Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | 0.38/0.33 | 1.12 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 33.6 Cr. | 10.6 | 10.6/4.43 | 0.25 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 157 Cr. | 146 | 194/99.8 | 35.1 | 33.2 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 32.9 Cr. | 257 | 310/140 | 23.5 | 26.7 | 0.39 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 6.55 Cr. | 1.34 | 1.73/0.91 | 59.6 | 2.52 | 0.00 % | 2.14 % | 2.15 % | 2.00 |
| Industry Average | 19,272.22 Cr | 570.43 | 144.55 | 119.27 | 0.53% | 14.92% | 20.95% | 6.84 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 570 | 625 | 659 | 709 | 725 | 766 | 784 | 780 | 813 | 867 | 870 | 905 | 915 |
| Expenses | 461 | 518 | 545 | 584 | 598 | 642 | 651 | 655 | 689 | 724 | 729 | 767 | 777 |
| Operating Profit | 109 | 107 | 114 | 126 | 127 | 123 | 134 | 125 | 124 | 143 | 141 | 139 | 137 |
| OPM % | 19% | 17% | 17% | 18% | 18% | 16% | 17% | 16% | 15% | 16% | 16% | 15% | 15% |
| Other Income | 26 | 32 | 6 | -0 | 2 | 1 | 3 | 5 | 4 | 17 | 13 | -5 | 11 |
| Interest | 2 | 5 | 8 | 9 | 9 | 13 | 13 | 9 | 9 | 11 | 12 | 10 | 9 |
| Depreciation | 11 | 17 | 20 | 20 | 20 | 21 | 22 | 27 | 20 | 20 | 17 | 19 | 18 |
| Profit before tax | 122 | 117 | 92 | 96 | 100 | 90 | 102 | 94 | 99 | 129 | 126 | 106 | 121 |
| Tax % | 31% | 27% | 27% | 25% | 27% | 28% | 24% | -1% | 28% | 0% | 25% | 23% | 24% |
| Net Profit | 84 | 86 | 67 | 73 | 74 | 65 | 78 | 94 | 72 | 129 | 95 | 81 | 92 |
| EPS in Rs | 25.68 | 26.30 | 21.33 | 23.77 | 22.91 | 20.50 | 24.56 | 29.85 | 23.18 | 41.68 | 30.67 | 26.20 | 29.75 |
Last Updated: August 1, 2025, 5:20 pm
Below is a detailed analysis of the quarterly data for Mastek Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 915.00 Cr.. The value appears strong and on an upward trend. It has increased from 905.00 Cr. (Mar 2025) to 915.00 Cr., marking an increase of 10.00 Cr..
- For Expenses, as of Jun 2025, the value is 777.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 767.00 Cr. (Mar 2025) to 777.00 Cr., marking an increase of 10.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 137.00 Cr.. The value appears to be declining and may need further review. It has decreased from 139.00 Cr. (Mar 2025) to 137.00 Cr., marking a decrease of 2.00 Cr..
- For OPM %, as of Jun 2025, the value is 15.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00%.
- For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from -5.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 16.00 Cr..
- For Interest, as of Jun 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 18.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 19.00 Cr. (Mar 2025) to 18.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 121.00 Cr.. The value appears strong and on an upward trend. It has increased from 106.00 Cr. (Mar 2025) to 121.00 Cr., marking an increase of 15.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 24.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 92.00 Cr.. The value appears strong and on an upward trend. It has increased from 81.00 Cr. (Mar 2025) to 92.00 Cr., marking an increase of 11.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 29.75. The value appears strong and on an upward trend. It has increased from 26.20 (Mar 2025) to 29.75, marking an increase of 3.55.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:23 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 923 | 1,013 | 527 | 560 | 817 | 1,033 | 1,071 | 1,722 | 2,184 | 2,563 | 3,055 | 3,455 | 3,557 |
| Expenses | 833 | 965 | 509 | 515 | 718 | 902 | 916 | 1,357 | 1,721 | 2,108 | 2,546 | 2,909 | 2,997 |
| Operating Profit | 90 | 47 | 18 | 45 | 100 | 132 | 156 | 364 | 463 | 456 | 509 | 546 | 560 |
| OPM % | 10% | 5% | 3% | 8% | 12% | 13% | 15% | 21% | 21% | 18% | 17% | 16% | 16% |
| Other Income | 11 | 14 | 15 | 12 | 21 | 25 | 17 | 28 | 36 | 64 | 12 | 30 | 36 |
| Interest | 1 | 1 | 0 | 4 | 6 | 6 | 4 | 8 | 8 | 25 | 44 | 42 | 41 |
| Depreciation | 33 | 37 | 16 | 15 | 19 | 17 | 25 | 45 | 43 | 67 | 90 | 75 | 73 |
| Profit before tax | 68 | 22 | 16 | 39 | 96 | 133 | 144 | 339 | 448 | 427 | 386 | 459 | 481 |
| Tax % | 24% | 20% | 17% | 17% | 27% | 24% | 21% | 26% | 26% | 27% | 19% | 18% | |
| Net Profit | 52 | 18 | 14 | 32 | 70 | 101 | 114 | 252 | 333 | 310 | 311 | 376 | 396 |
| EPS in Rs | 23.37 | 7.86 | 5.97 | 13.86 | 29.53 | 42.33 | 44.82 | 82.97 | 98.32 | 95.99 | 97.36 | 121.50 | 128.30 |
| Dividend Payout % | 19% | 32% | 42% | 25% | 20% | 20% | 18% | 17% | 19% | 20% | 20% | 19% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -65.38% | -22.22% | 128.57% | 118.75% | 44.29% | 12.87% | 121.05% | 32.14% | -6.91% | 0.32% | 20.90% |
| Change in YoY Net Profit Growth (%) | 0.00% | 43.16% | 150.79% | -9.82% | -74.46% | -31.41% | 108.18% | -88.91% | -39.05% | 7.23% | 20.58% |
Mastek Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 26% |
| 3 Years: | 17% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 25% |
| 3 Years: | 9% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 29% |
| 3 Years: | 11% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 20% |
| 3 Years: | 17% |
| Last Year: | 16% |
Last Updated: Unknown
Balance Sheet
Last Updated: September 10, 2025, 2:04 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 12 | 12 | 12 | 12 | 12 | 13 | 15 | 15 | 15 | 15 |
| Reserves | 549 | 585 | 308 | 457 | 537 | 704 | 778 | 846 | 1,056 | 1,668 | 2,072 | 2,447 |
| Borrowings | 2 | 29 | 0 | 66 | 70 | 70 | 335 | 273 | 203 | 404 | 519 | 583 |
| Other Liabilities | 192 | 207 | 108 | 170 | 202 | 179 | 763 | 1,146 | 1,193 | 1,024 | 1,045 | 803 |
| Total Liabilities | 754 | 832 | 428 | 705 | 821 | 966 | 1,888 | 2,277 | 2,467 | 3,111 | 3,652 | 3,848 |
| Fixed Assets | 261 | 279 | 66 | 180 | 179 | 167 | 857 | 807 | 841 | 1,740 | 1,950 | 1,818 |
| CWIP | 0 | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 4 | 7 | 1 | 2 |
| Investments | 84 | 54 | 50 | 274 | 284 | 396 | 276 | 234 | 26 | 69 | 94 | 178 |
| Other Assets | 409 | 498 | 312 | 251 | 356 | 401 | 754 | 1,235 | 1,596 | 1,296 | 1,607 | 1,851 |
| Total Assets | 754 | 832 | 428 | 705 | 821 | 966 | 1,888 | 2,277 | 2,467 | 3,111 | 3,652 | 3,848 |
Below is a detailed analysis of the balance sheet data for Mastek Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,447.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,072.00 Cr. (Mar 2024) to 2,447.00 Cr., marking an increase of 375.00 Cr..
- For Borrowings, as of Mar 2025, the value is 583.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 519.00 Cr. (Mar 2024) to 583.00 Cr., marking an increase of 64.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 803.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,045.00 Cr. (Mar 2024) to 803.00 Cr., marking a decrease of 242.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 3,848.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,652.00 Cr. (Mar 2024) to 3,848.00 Cr., marking an increase of 196.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,818.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,950.00 Cr. (Mar 2024) to 1,818.00 Cr., marking a decrease of 132.00 Cr..
- For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Mar 2025, the value is 178.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Mar 2024) to 178.00 Cr., marking an increase of 84.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,851.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,607.00 Cr. (Mar 2024) to 1,851.00 Cr., marking an increase of 244.00 Cr..
- For Total Assets, as of Mar 2025, the value is 3,848.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,652.00 Cr. (Mar 2024) to 3,848.00 Cr., marking an increase of 196.00 Cr..
Notably, the Reserves (2,447.00 Cr.) exceed the Borrowings (583.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 88.00 | 18.00 | 18.00 | -21.00 | 30.00 | 62.00 | -179.00 | 91.00 | 260.00 | 52.00 | -10.00 | -37.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 46 | 48 | 67 | 55 | 78 | 74 | 108 | 79 | 73 | 72 | 67 | 78 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 46 | 48 | 67 | 55 | 78 | 74 | 108 | 79 | 73 | 72 | 67 | 78 |
| Working Capital Days | 26 | 25 | 38 | 29 | 15 | 38 | 4 | -35 | -20 | 34 | -1 | 28 |
| ROCE % | 12% | 5% | 3% | 10% | 17% | 19% | 16% | 26% | 32% | 23% | 18% | 17% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Technology Fund | 250,560 | 0.51 | 55.34 | 250,560 | 2025-04-22 15:57:38 | 0% |
| Tata Digital India Fund | 155,070 | 0.43 | 36.82 | 155,070 | 2025-04-22 15:57:38 | 0% |
| Nippon India Nifty Smallcap 250 Index Fund | 9,532 | 0.27 | 2.26 | 9,532 | 2025-04-22 15:57:38 | 0% |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 5,824 | 0.27 | 1.38 | 5,824 | 2025-04-22 15:57:38 | 0% |
| SBI Nifty Smallcap 250 Index Fund | 4,560 | 0.27 | 1.08 | 4,560 | 2025-04-22 15:56:55 | 0% |
| Quantum Small Cap Fund | 2,071 | 1.71 | 0.49 | 2,071 | 2025-04-22 15:56:55 | 0% |
| Motilal Oswal Nifty 500 Index Fund | 633 | 0.03 | 0.15 | 633 | 2025-04-22 15:56:55 | 0% |
| Edelweiss Nifty Smallcap 250 Index Fund | 239 | 0.27 | 0.06 | 239 | 2025-04-22 15:56:55 | 0% |
| Groww Nifty Total Market Index Fund | 42 | 0.02 | 0.01 | 42 | 2025-04-22 15:57:38 | 0% |
| Motilal Oswal Nifty 500 ETF | 27 | 0.02 | 0.01 | 27 | 2025-04-22 15:56:55 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 121.78 | 98.01 | 97.23 | 106.52 | 84.92 |
| Diluted EPS (Rs.) | 120.65 | 97.25 | 95.53 | 106.52 | 81.88 |
| Cash EPS (Rs.) | 145.78 | 129.99 | 123.74 | 125.35 | 117.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 795.84 | 676.85 | 581.42 | 406.96 | 336.32 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 795.84 | 676.85 | 581.42 | 406.96 | 336.32 |
| Revenue From Operations / Share (Rs.) | 1116.75 | 990.53 | 839.90 | 727.46 | 682.19 |
| PBDIT / Share (Rs.) | 183.82 | 170.13 | 161.91 | 166.09 | 155.46 |
| PBIT / Share (Rs.) | 159.54 | 140.98 | 139.83 | 151.81 | 137.65 |
| PBT / Share (Rs.) | 148.40 | 125.22 | 140.03 | 149.25 | 134.44 |
| Net Profit / Share (Rs.) | 121.50 | 100.83 | 101.66 | 111.07 | 99.74 |
| NP After MI And SOA / Share (Rs.) | 121.50 | 97.37 | 96.01 | 98.31 | 82.94 |
| PBDIT Margin (%) | 16.45 | 17.17 | 19.27 | 22.83 | 22.78 |
| PBIT Margin (%) | 14.28 | 14.23 | 16.64 | 20.86 | 20.17 |
| PBT Margin (%) | 13.28 | 12.64 | 16.67 | 20.51 | 19.70 |
| Net Profit Margin (%) | 10.88 | 10.17 | 12.10 | 15.26 | 14.62 |
| NP After MI And SOA Margin (%) | 10.88 | 9.83 | 11.43 | 13.51 | 12.15 |
| Return on Networth / Equity (%) | 15.26 | 14.38 | 17.40 | 27.54 | 17.93 |
| Return on Capital Employeed (%) | 16.88 | 16.75 | 17.74 | 27.85 | 22.21 |
| Return On Assets (%) | 9.73 | 8.14 | 9.32 | 11.86 | 9.11 |
| Long Term Debt / Equity (X) | 0.15 | 0.15 | 0.15 | 0.11 | 0.16 |
| Total Debt / Equity (X) | 0.22 | 0.23 | 0.22 | 0.17 | 0.16 |
| Asset Turnover Ratio (%) | 0.91 | 0.89 | 0.18 | 0.17 | 0.16 |
| Current Ratio (X) | 1.95 | 1.42 | 1.69 | 1.78 | 1.87 |
| Quick Ratio (X) | 1.95 | 1.42 | 1.69 | 1.78 | 1.87 |
| Dividend Payout Ratio (NP) (%) | 15.60 | 19.39 | 19.59 | 16.10 | 6.50 |
| Dividend Payout Ratio (CP) (%) | 13.00 | 14.92 | 15.93 | 14.06 | 5.35 |
| Earning Retention Ratio (%) | 84.40 | 80.61 | 80.41 | 83.90 | 93.50 |
| Cash Earning Retention Ratio (%) | 87.00 | 85.08 | 84.07 | 85.94 | 94.65 |
| Interest Coverage Ratio (X) | 13.52 | 11.80 | 19.99 | 64.92 | 48.44 |
| Interest Coverage Ratio (Post Tax) (X) | 9.76 | 8.09 | 12.53 | 44.41 | 32.08 |
| Enterprise Value (Cr.) | 6839.86 | 7924.50 | 4956.73 | 9576.73 | 2360.43 |
| EV / Net Operating Revenue (X) | 1.98 | 2.59 | 1.93 | 4.39 | 1.37 |
| EV / EBITDA (X) | 12.03 | 15.10 | 10.03 | 19.21 | 6.02 |
| MarketCap / Net Operating Revenue (X) | 1.95 | 2.56 | 1.83 | 4.56 | 1.79 |
| Retention Ratios (%) | 84.39 | 80.60 | 80.40 | 83.89 | 93.49 |
| Price / BV (X) | 2.74 | 3.75 | 2.79 | 9.30 | 2.64 |
| Price / Net Operating Revenue (X) | 1.95 | 2.56 | 1.83 | 4.56 | 1.79 |
| EarningsYield | 0.05 | 0.03 | 0.06 | 0.02 | 0.06 |
After reviewing the key financial ratios for Mastek Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 121.78. This value is within the healthy range. It has increased from 98.01 (Mar 24) to 121.78, marking an increase of 23.77.
- For Diluted EPS (Rs.), as of Mar 25, the value is 120.65. This value is within the healthy range. It has increased from 97.25 (Mar 24) to 120.65, marking an increase of 23.40.
- For Cash EPS (Rs.), as of Mar 25, the value is 145.78. This value is within the healthy range. It has increased from 129.99 (Mar 24) to 145.78, marking an increase of 15.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 795.84. It has increased from 676.85 (Mar 24) to 795.84, marking an increase of 118.99.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 795.84. It has increased from 676.85 (Mar 24) to 795.84, marking an increase of 118.99.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,116.75. It has increased from 990.53 (Mar 24) to 1,116.75, marking an increase of 126.22.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 183.82. This value is within the healthy range. It has increased from 170.13 (Mar 24) to 183.82, marking an increase of 13.69.
- For PBIT / Share (Rs.), as of Mar 25, the value is 159.54. This value is within the healthy range. It has increased from 140.98 (Mar 24) to 159.54, marking an increase of 18.56.
- For PBT / Share (Rs.), as of Mar 25, the value is 148.40. This value is within the healthy range. It has increased from 125.22 (Mar 24) to 148.40, marking an increase of 23.18.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 121.50. This value is within the healthy range. It has increased from 100.83 (Mar 24) to 121.50, marking an increase of 20.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 121.50. This value is within the healthy range. It has increased from 97.37 (Mar 24) to 121.50, marking an increase of 24.13.
- For PBDIT Margin (%), as of Mar 25, the value is 16.45. This value is within the healthy range. It has decreased from 17.17 (Mar 24) to 16.45, marking a decrease of 0.72.
- For PBIT Margin (%), as of Mar 25, the value is 14.28. This value is within the healthy range. It has increased from 14.23 (Mar 24) to 14.28, marking an increase of 0.05.
- For PBT Margin (%), as of Mar 25, the value is 13.28. This value is within the healthy range. It has increased from 12.64 (Mar 24) to 13.28, marking an increase of 0.64.
- For Net Profit Margin (%), as of Mar 25, the value is 10.88. This value exceeds the healthy maximum of 10. It has increased from 10.17 (Mar 24) to 10.88, marking an increase of 0.71.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.88. This value is within the healthy range. It has increased from 9.83 (Mar 24) to 10.88, marking an increase of 1.05.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.26. This value is within the healthy range. It has increased from 14.38 (Mar 24) to 15.26, marking an increase of 0.88.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.88. This value is within the healthy range. It has increased from 16.75 (Mar 24) to 16.88, marking an increase of 0.13.
- For Return On Assets (%), as of Mar 25, the value is 9.73. This value is within the healthy range. It has increased from 8.14 (Mar 24) to 9.73, marking an increase of 1.59.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.15.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.23 (Mar 24) to 0.22, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.91. It has increased from 0.89 (Mar 24) to 0.91, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.95, marking an increase of 0.53.
- For Quick Ratio (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.95, marking an increase of 0.53.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 15.60. This value is below the healthy minimum of 20. It has decreased from 19.39 (Mar 24) to 15.60, marking a decrease of 3.79.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 13.00. This value is below the healthy minimum of 20. It has decreased from 14.92 (Mar 24) to 13.00, marking a decrease of 1.92.
- For Earning Retention Ratio (%), as of Mar 25, the value is 84.40. This value exceeds the healthy maximum of 70. It has increased from 80.61 (Mar 24) to 84.40, marking an increase of 3.79.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.00. This value exceeds the healthy maximum of 70. It has increased from 85.08 (Mar 24) to 87.00, marking an increase of 1.92.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.52. This value is within the healthy range. It has increased from 11.80 (Mar 24) to 13.52, marking an increase of 1.72.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.76. This value is within the healthy range. It has increased from 8.09 (Mar 24) to 9.76, marking an increase of 1.67.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6,839.86. It has decreased from 7,924.50 (Mar 24) to 6,839.86, marking a decrease of 1,084.64.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has decreased from 2.59 (Mar 24) to 1.98, marking a decrease of 0.61.
- For EV / EBITDA (X), as of Mar 25, the value is 12.03. This value is within the healthy range. It has decreased from 15.10 (Mar 24) to 12.03, marking a decrease of 3.07.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 2.56 (Mar 24) to 1.95, marking a decrease of 0.61.
- For Retention Ratios (%), as of Mar 25, the value is 84.39. This value exceeds the healthy maximum of 70. It has increased from 80.60 (Mar 24) to 84.39, marking an increase of 3.79.
- For Price / BV (X), as of Mar 25, the value is 2.74. This value is within the healthy range. It has decreased from 3.75 (Mar 24) to 2.74, marking a decrease of 1.01.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 2.56 (Mar 24) to 1.95, marking a decrease of 0.61.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mastek Ltd:
- Net Profit Margin: 10.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.88% (Industry Average ROCE: 14.92%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.26% (Industry Average ROE: 20.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.76
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.95
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 18.3 (Industry average Stock P/E: 144.55)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.88%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 804/805, President House, Opp. C N Vidyalaya, Ahmedabad Gujarat 380006 | investor_grievances@mastek.com http://www.mastek.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashank Desai | Chairman, Non Ind & Non Exe Director |
| Mr. Umang Nahata | WholeTime Director & CEO |
| Mr. Ketan Mehta | Non Exe.Non Ind.Director |
| Mr. Suresh Vaswani | Ind. Non-Executive Director |
| Mr. Rajeev Kumar Grover | Ind. Non-Executive Director |
| Ms. Marilyn Jones | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Mastek Ltd?
Mastek Ltd's intrinsic value (as of 03 November 2025) is 2058.07 which is 5.29% lower the current market price of 2,173.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 6,731 Cr. market cap, FY2025-2026 high/low of 3,375/1,883, reserves of ₹2,447 Cr, and liabilities of 3,848 Cr.
What is the Market Cap of Mastek Ltd?
The Market Cap of Mastek Ltd is 6,731 Cr..
What is the current Stock Price of Mastek Ltd as on 03 November 2025?
The current stock price of Mastek Ltd as on 03 November 2025 is 2,173.
What is the High / Low of Mastek Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mastek Ltd stocks is 3,375/1,883.
What is the Stock P/E of Mastek Ltd?
The Stock P/E of Mastek Ltd is 18.3.
What is the Book Value of Mastek Ltd?
The Book Value of Mastek Ltd is 864.
What is the Dividend Yield of Mastek Ltd?
The Dividend Yield of Mastek Ltd is 1.06 %.
What is the ROCE of Mastek Ltd?
The ROCE of Mastek Ltd is 17.3 %.
What is the ROE of Mastek Ltd?
The ROE of Mastek Ltd is 16.1 %.
What is the Face Value of Mastek Ltd?
The Face Value of Mastek Ltd is 5.00.